Safety and effectivness of Open- Label Melperone in the treatment of Patients with Psycosis Associated with Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2012
At a glance
- Drugs Melperone (Primary)
- Indications Parkinson's disease; Psychotic disorders
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2011 New trial record